TDA,
hope for both!
Unilife Landscape as I know it to be.
AbbVie (?)
Amgen (?)
Astrazenca ($)
Hikma ($)
Novartis ($)
Sanofi ($)
Sanofi #2 ($)
Unknown (?)
Oculars
Unknown (?)
Programs
Unknown (?)
Patent count
While we are aware of the short term events ongoing, amidst many other challenges, the landscape to me is impressive. I repeat. We wait! RRM